{"id":"W3003349858","doi":"10.1016/j.eururo.2020.01.019","title":"Re: Clinical Efficacy and Biomarker Analysis of Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial","year":2020,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Atezolizumab; Oncology; Urothelial carcinoma; Biomarker; Bladder cancer; Internal medicine; Clinical trial; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005256181,0.0007407488,0.001745209,0.0004656918,0.001202214,0.0027489,0.001248215,0.01599345,0.007142242],"category_scores_gemma":[0.01916726,0.0005011475,0.001071383,0.0006105737,0.0008529075,0.001496928,0.000627168,0.01176596,0.007008128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003817398,"about_ca_system_score_gemma":0.003825395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002960637,"about_ca_topic_score_gemma":0.00793281,"domain_scores_codex":[0.9968017,0.0015024,0.0003384743,0.0003519717,0.0006077364,0.0003978136],"domain_scores_gemma":[0.9894696,0.006345965,0.0008297472,0.0003471387,0.001191708,0.001815766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007522424,0.0002144828,0.003006491,0.000171824,0.0001349489,0.0008709391,0.00004836808,0.0001828459,0.0008993756,0.001513741,0.9522576,0.03317684],"study_design_scores_gemma":[0.02071505,0.002508464,0.01614045,0.0009862006,0.0006339132,0.001670825,0.0002605532,0.002804951,0.00265613,0.01198629,0.9394285,0.0002085688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.007023396,0.004570219,0.0002326682,0.9378269,0.03105978,0.0001758095,0.003230332,0.0001314199,0.01574938],"genre_scores_gemma":[0.02421161,0.001576589,0.0005880087,0.9098243,0.0403217,0.0004173678,0.001342409,0.00008934653,0.02162871],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01599345,"threshold_uncertainty_score":0.02779764,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07430930771093772,"score_gpt":0.3423088906009568,"score_spread":0.267999582890019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}